Anthony Dobranowski
Directeur/Membre du Conseil chez CRESCITA THERAPEUTICS INC.
Fortune : 31 900 $ au 31/05/2024
Profil
Anthony E.
Dobranowski is currently the Lead Independent Director at Crescita Therapeutics, Inc. He previously held positions as the Vice Chairman, President, CFO & Executive VP at Tesma International, Inc. from 1995 to 2012, as an Independent Director at Nuvo Pharmaceuticals, Inc. from 2011 to 2023, and as the Vice President at Magna International, Inc. from 2005 to 2007.
He also served as a Trustee at Heating Oil Partners Income Fund.
Mr. Dobranowski obtained his undergraduate degree and MBA from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2023 | 100 000 ( 0,51% ) | 31 900 $ | 31/05/2024 |
Postes actifs de Anthony Dobranowski
| Sociétés | Poste | Début |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/03/2016 |
Anciens postes connus de Anthony Dobranowski
| Sociétés | Poste | Fin |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/03/2023 |
| MAGNA INTERNATIONAL INC. | Corporate Officer/Principal | 01/09/2007 |
Tesma International, Inc.
 Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | President | - |
| Heating Oil Partners Income Fund | Directeur/Membre du Conseil | - |
Formation de Anthony Dobranowski
| University of Toronto | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MAGNA INTERNATIONAL INC. | Producer Manufacturing |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Tesma International, Inc.
Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | Producer Manufacturing |
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
| Heating Oil Partners Income Fund | Miscellaneous |
